Literature DB >> 24389071

Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.

Deeksha S Bali1, Jennifer L Goldstein2, Keri Fredrickson3, Catherine Rehder4, Anne Boney5, Stephanie Austin6, David A Weinstein7, Richard Lutz8, Avihu Boneh9, Priya S Kishnani10.   

Abstract

Liver phosphorylase b kinase (PhK) deficiency (glycogen storage disease type IX), one of the most common causes of glycogen storage disease, is caused by mutations in the PHKA2, PHKB, and PHKG2 genes. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. Clinical severity varies widely. Autosomal recessive mutations in the PHKG2 gene, which cause about 10-15% of cases, have been associated with severe symptoms including increased risk of liver cirrhosis in childhood. We have summarized the molecular, biochemical, and clinical findings in five patients, age 5-16 years, diagnosed with liver PhK deficiency caused by PHKG2 gene mutations. We have identified five novel and two previously reported mutations in the PHKG2 gene in these five patients. Clinical severity was variable among these patients. Histopathological studies were performed for four of the patients on liver biopsy samples, all of which showed signs of fibrosis but not cirrhosis. One of the patients (aged 9 years) developed a liver adenoma which later resolved. All patients are currently doing well. Their clinical symptoms have improved with age and treatment. These cases add to the current knowledge of clinical variability in patients with PHKG2 mutations. Long term studies, involving follow-up of these patients into adulthood, are needed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glycogen storage disease type IX; Hypoglycemia; Liver adenoma; PHKG2 gene; Phosphorylase b kinase deficiency

Mesh:

Substances:

Year:  2013        PMID: 24389071      PMCID: PMC3952947          DOI: 10.1016/j.ymgme.2013.12.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  31 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Autosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB).

Authors:  I E van den Berg; E A van Beurden; J B de Klerk; O P van Diggelen; H E Malingré; M M Boer; R Berger
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.

Authors:  S E Antonarakis
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene.

Authors:  B Burwinkel; L Amat; R G Gray; N Matsuo; K Muroya; K Narisawa; R J Sokol; M A Vilaseca; M W Kilimann
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

5.  Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB).

Authors:  B Burwinkel; A J Maichele; O Aagenaes; H D Bakker; A Lerner; Y S Shin; J A Strachan; M W Kilimann
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

6.  Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans.

Authors:  A J Maichele; B Burwinkel; I Maire; O Søvik; M W Kilimann
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

7.  Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis.

Authors:  B Burwinkel; S Shiomi; A Al Zaben; M W Kilimann
Journal:  Hum Mol Genet       Date:  1998-01       Impact factor: 6.150

8.  Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB).

Authors:  B Burwinkel; S W Moses; M W Kilimann
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

Review 9.  Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure.

Authors:  R J Brushia; D A Walsh
Journal:  Front Biosci       Date:  1999-09-15

Review 10.  Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy.

Authors:  J I Wolfsdorf; I A Holm; D A Weinstein
Journal:  Endocrinol Metab Clin North Am       Date:  1999-12       Impact factor: 4.741

View more
  17 in total

1.  Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.

Authors:  Samuela A Fernandes; Gabrielle E Cooper; Rebecca Anne Gibson; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2020-10-10       Impact factor: 4.797

Review 2.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

3.  Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.

Authors:  Katalin M Ross; Iris A Ferrecchia; Kathryn R Dahlberg; Monika Dambska; Patrick T Ryan; David A Weinstein
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

4.  Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.

Authors:  Deeksha S Bali; Jennifer L Goldstein; Keri Fredrickson; Stephanie Austin; Surekha Pendyal; Catherine Rehder; Priya S Kishnani
Journal:  JIMD Rep       Date:  2017-03-12

5.  Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease.

Authors:  Irene J Hoogeveen; Rixt M van der Ende; Francjan J van Spronsen; Foekje de Boer; M Rebecca Heiner-Fokkema; Terry G J Derks
Journal:  JIMD Rep       Date:  2015-11-03

Review 6.  Investigation and management of the hepatic glycogen storage diseases.

Authors:  Kaustuv Bhattacharya
Journal:  Transl Pediatr       Date:  2015-07

7.  A very rare case report of glycogen storage disease type IXc with novel PHKG2 variants.

Authors:  Yongxian Shao; Taolin Li; Minyan Jiang; Jianan Xu; Yonglan Huang; Xiuzhen Li; Ruidan Zheng; Li Liu
Journal:  BMC Pediatr       Date:  2022-05-12       Impact factor: 2.567

Review 8.  Rhabdomyolysis: a genetic perspective.

Authors:  Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan
Journal:  Orphanet J Rare Dis       Date:  2015-05-02       Impact factor: 4.123

9.  Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children.

Authors:  Catarina Leuzinger Dias; Inês Maio; José Ricardo Brandão; Edite Tomás; Esmeralda Martins; Ermelinda Santos Silva
Journal:  GE Port J Gastroenterol       Date:  2019-03-14

10.  Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly.

Authors:  Jung Ah Kim; Ja Hye Kim; Beom Hee Lee; Gu-Hwan Kim; Yoon S Shin; Han-Wook Yoo; Kyung Mo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.